Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine, founded in 1970, is based in Lianyungang, Jiangsu Province, China, and has evolved into a leading pharmaceutical enterprise. Specializing in key business segments such as oncology, anesthesia and analgesia, cardiovascular and cerebrovascular, immunology, and metabolic diseases, the company has attained a reputation for its pharmaceutical products across various brands, with a particular emphasis on generic and innovative new drugs. While headquartered in China, Jiangsu Hengrui Medicine has a robust international footprint, marketing its products and services in various countries including the United States, Europe, Japan, and several emerging economies. The company’s global expansion reflects the dynamic nature of the healthcare industry and is influenced by factors such as healthcare demand, regulatory conditions, and strategic market entry. As a result, Jiangsu Hengrui Medicine's presence in these markets contributes to its position as a prominent player in the global pharmaceutical landscape. (Powered by AI)